Structure Therapeutics Inc.
GPCR
$54.51
-$0.19-0.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.74% | -330.18% | 150.23% | -6.57% | -31.66% |
| Total Depreciation and Amortization | -2.73% | -20.16% | 93.67% | 30.24% | 6.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.57% | 309.03% | -189.55% | 29.39% | 229.13% |
| Change in Net Operating Assets | -130.05% | 186.95% | -1,086.47% | 208.53% | 145.32% |
| Cash from Operations | -888.47% | 123.65% | -26.32% | 6.53% | -4.46% |
| Capital Expenditure | 103.55% | 20.99% | 4.83% | -577.59% | 26.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -1.30% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 115.02% | -1,043.51% | 199.32% | -207.59% | 43.17% |
| Cash from Investing | 114.99% | -985.19% | 213.83% | -200.77% | 43.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 139.93% | -99.88% | 1,129.63% | 11,009.28% | -46.42% |
| Repurchase of Common Stock | 100.00% | -- | 100.00% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 97.04% | -62.34% | -- | -- |
| Cash from Financing | 219.69% | -100.25% | 1,154.36% | 10,770.99% | -36.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.00% | -169.39% | 1,679.41% | -765.11% | 70.67% |